Related references
Note: Only part of the references are listed.Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population
Maikel V. W. van der Velden et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Florian Krammer et al.
JOURNAL OF VIROLOGY (2014)
Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection : a descriptive study
HaiYing Chen et al.
LANCET (2014)
Universal influenza virus vaccines: need for clinical trials
Florian Krammer et al.
NATURE IMMUNOLOGY (2014)
Stability of neuraminidase in inactivated influenza vaccines
Ishrat Sultana et al.
VACCINE (2014)
One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge
Miriam Klausberger et al.
VACCINE (2014)
Toward a Universal Influenza Virus Vaccine: Prospects and Challenges
Natalie Pica et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
Tracey M. Doyle et al.
ANTIVIRAL RESEARCH (2013)
A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains
Tracey M. Doyle et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
Ma Teresa Herrera et al.
BMC INFECTIOUS DISEASES (2013)
Origin and Molecular Characteristics of a Novel 2013 Avian Influenza A(H6N1) Virus Causing Human Infection in Taiwan
Jian Yuan et al.
CLINICAL INFECTIOUS DISEASES (2013)
Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
Hongquan Wan et al.
JOURNAL OF VIROLOGY (2013)
H3N2 Influenza Virus Infection Induces Broadly Reactive Hemagglutinin Stalk Antibodies in Humans and Mice
Irina Margine et al.
JOURNAL OF VIROLOGY (2013)
Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine
Steven Rockman et al.
JOURNAL OF VIROLOGY (2013)
A Mutant Influenza Virus That Uses an N1 Neuraminidase as the Receptor-Binding Protein
Kathryn A. Hooper et al.
JOURNAL OF VIROLOGY (2013)
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
Florian Krammer et al.
JOURNAL OF VIROLOGY (2013)
A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
Louis F. Fries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase
Miriam Cohen et al.
VIROLOGY JOURNAL (2013)
Influenza virus hemagglutinin stalk-based antibodies and vaccines
Florian Krammer et al.
CURRENT OPINION IN VIROLOGY (2013)
New World Bats Harbor Diverse Influenza A Viruses
Suxiang Tong et al.
PLOS PATHOGENS (2013)
Immunodominance: A pivotal principle in host response to viral infections
Ali Akram et al.
CLINICAL IMMUNOLOGY (2012)
Influenza neuraminidase
Gillian M. Air
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2012)
A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
Richard Fritz et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice
Florian Krammer et al.
JOURNAL OF VIROLOGY (2012)
Influenza Virus Neuraminidases with Reduced Enzymatic Activity That Avidly Bind Sialic Acid Receptors
Xueyong Zhu et al.
JOURNAL OF VIROLOGY (2012)
Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
Rong Hai et al.
JOURNAL OF VIROLOGY (2012)
Expression, purification and characterization of low-glycosylation influenza neuraminidase in α-1,6-mannosyltransferase defective Pichia pastoris
Yi-Li Yang et al.
MOLECULAR BIOLOGY REPORTS (2012)
Evolutionary History and Phylodynamics of Influenza A and B Neuraminidase (NA) Genes Inferred from Large-Scale Sequence Analyses
Jianpeng Xu et al.
PLOS ONE (2012)
A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A Virus
Chia-Ying Wu et al.
PLOS ONE (2012)
Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
Glendie Marcelin et al.
REVIEWS IN MEDICAL VIROLOGY (2012)
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines
Robert B. Couch et al.
VACCINE (2012)
Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection
Fu-Shi Quan et al.
VIROLOGY (2012)
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice
Judith D. Easterbrook et al.
VIROLOGY (2012)
New technologies for influenza vaccines
Philip R. Dormitzer et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Influenza Virus A (H10N7) in Chickens and Poultry Abattoir Workers, Australia
George G. Arzey et al.
EMERGING INFECTIOUS DISEASES (2012)
Revisiting the 1976 Swine Flu Vaccine Clinical Trials: Cross-reactive Hemagglutinin and Neuraminidase Antibodies and Their Role in Protection Against the 2009 H1N1 Pandemic Virus in Mice
Hang Xie et al.
CLINICAL INFECTIOUS DISEASES (2011)
Influenza viral neuraminidase: the forgotten antigen
Bert E. Johansson et al.
EXPERT REVIEW OF VACCINES (2011)
An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses
Yoko Shoji et al.
HUMAN VACCINES (2011)
Evidence of Infection with H4 and H11 Avian Influenza Viruses among Lebanese Chicken Growers
Ghazi Kayali et al.
PLOS ONE (2011)
A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
Glendie Marcelin et al.
PLOS ONE (2011)
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
Matthew R. Sandbulte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Why Do Influenza Virus Subtypes Die Out? A Hypothesis
Peter Palese et al.
MBIO (2011)
Inactivated Seasonal Influenza Vaccines Increase Serum Antibodies to the Neuraminidase of Pandemic Influenza A(H1N1) 2009 Virus in an Age-Dependent Manner
Glendie Marcelin et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets
Berend Jan Bosch et al.
JOURNAL OF VIROLOGY (2010)
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
Taia T. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alternative influenza vaccines made by insect cells
Florian Krammer et al.
TRENDS IN MOLECULAR MEDICINE (2010)
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects
Thomas R. Cate et al.
VACCINE (2010)
Evidence of Previous Avian Influenza Infection among US Turkey Workers
G. Kayali et al.
ZOONOSES AND PUBLIC HEALTH (2010)
Transforming Growth Factor-β: Activation by Neuraminidase and Role in Highly Pathogenic H5N1 Influenza Pathogenesis
Christina M. Carlson et al.
PLOS PATHOGENS (2010)
Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
Taia T. Wang et al.
PLOS PATHOGENS (2010)
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift
Scott E. Hensley et al.
SCIENCE (2009)
WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008
Rick A. Bright et al.
VACCINE (2009)
Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus
Kristien Van Reeth et al.
VACCINE (2009)
Insights into infectious disease in the era of Hippocrates
Georgios Pappas et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase
Xiaojin Xu et al.
JOURNAL OF VIROLOGY (2008)
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007
Maryna Eichelberger et al.
VACCINE (2008)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection
Matthew J. Sylte et al.
VACCINE (2007)
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus
Fu-Shi Quan et al.
JOURNAL OF VIROLOGY (2007)
An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-Antibody complex
L Venkatramani et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Cell-mediated protection in influenza infection
PG Thomas et al.
EMERGING INFECTIOUS DISEASES (2006)
Mapping the antigenic and genetic evolution of influenza virus
DJ Smith et al.
SCIENCE (2004)
Activation of TGF-β by Leishmania chagasi:: Importance for parasite survival in macrophages
KR Gantt et al.
JOURNAL OF IMMUNOLOGY (2003)
Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada
Y Abed et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition
BE Johansson et al.
VACCINE (2002)
Updating the accounts: global mortality of the 1918-1920 Spanish influenza pandemic
NPAS Johnson et al.
BULLETIN OF THE HISTORY OF MEDICINE (2002)
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase
Z Chen et al.
VACCINE (2000)
Share Paper
